
ISN ® Marks 15-Year Partnership with Federated Co-operatives Limited
'Over the past 15 years, ISN has helped FCL align our contractor management practices with industry standards while helping ensure contractors are compliant with FCL safety and risk protocols,' said Mitchell Clark, Senior Manager of Facilities Management at FCL. 'As we expand our use of ISNetworld to additional co-op retail operations, FCL is also exploring implementing ISNetworld tools and services including RAVS 360 ™ and API integrations to further enhance safety culture and efficiency.'
Based in Saskatoon, Saskatchewan, FCL supports a network of retail co-ops that serve local communities, providing food, fuel, agricultural products, and building solutions. ISN's partnership with FCL began with the Refinery Complex in Regina, Saskatchewan, and has since expanded to six additional business units including distribution centers, agriculture operations, and facilities development.
'FCL continues to be a valued partner, demonstrating an unwavering commitment to safety, operational excellence, and the well-being of the communities it serves,' said Kim Ritchie, Senior Vice President at ISN. 'ISN is proud to celebrate this milestone with FCL and to continue providing the tools and services that help ensure workers return home safely each day.'
For more information on ISN's industry-leading software and services, visit isn.com.
About ISN
ISN is the global leader in contractor and supplier information management, with more than 20 years of experience connecting more than 850 Hiring Clients in capital-intensive industries with 85,000 active contractors and suppliers to promote safety, health, and sustainability in the workplace. ISN's brands include ISNetworld ®, a global online contractor and supplier management platform, Transparency-One ®, a responsible sourcing platform built to bring transparency to supply chain management, and Empower ®, a worker-level app built to keep workers moving forward.
ISN has 14 offices around the globe which provide award-winning support and training for its customers in more than 85 countries. ISN takes pride in leading worldwide efforts to improve the efficiency and effectiveness of contractor and supplier management systems and in serving as a world-class forum for sharing industry best practices, benchmarking performance, providing data insights among its members, and helping decision makers, including board members, ensure contractor and supplier risk is assessed and monitored. For more information, visit isn.com.
About Federated Co-operatives Limited
FCL is focused on providing more than 150 local co-ops across Western Canada with strategy, leadership, wholesaling, manufacturing, logistics, operational support, business-enabling services, and marketing support. FCL's workforce of over 27,000 employees serves more than 2 million active individual members and many more non-member customers at 1,600+ retail locations in more than 650 communities. More information is available at fcl.crs.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
an hour ago
- Business Wire
Introducing Cambridge Forum 2025: Tech for Good
CAMBRIDGE, England--(BUSINESS WIRE)-- Cambridge Forum 2025, themed 'Tech for Good', is set to bring together global technology leaders, development innovators, policymakers, entrepreneurs, and academics in Cambridge this September. This two-day event discusses technology as a force for inclusive empowerment and positive social impact. Our Vision: From Underserved to Unstoppable At Cambridge Forum, we believe that technology can transform lives—especially in underserved communities. Rooted in Cambridge's academic and innovation ecosystem, we will foster collaboration across technology, development, academia, policy, and the private sector to bring solutions to the world's pressing challenges. Taking place in the historic city of Cambridge—a global hub for intellectual discovery—the Forum aims to be a permanent platform for inclusive collaboration across disciplines, sectors, and geographies. 'We believe the world's toughest challenges can't be solved in silos. Cambridge Forum offers a shared space to design, build, and scale innovation for good,' said Dr. Ehab Shanti, Founding Director of Cambridge Forum. 'AI undoubtedly presents enormous derivative challenges, but it also creates significant opportunities. Cambridge Forum will explore both,' he added. Cambridge Forum 2025 will feature a high-impact line-up of world-class speakers and changemakers, including: Marty Neumeier – Highly influential American author, designer, and business advisor focused on the intersection of design, branding, and innovation will deliver a session on 'Goodness as Corporate DNA'. Jaideep Prabhu – Co-author of Jugaad Innovation: Think Frugal, Be Flexible, will deliver a session on" Frugal Innovation: Leveraging Digital Public Infrastructure for Inclusive Artificial Intelligence'. Dr. Gareth Corbett, Chief Medical Officer, Onion AI will discuss, 'Tech for Good, The Case of AI and Health'. Henning Grosse Ruse Khan - Professor of Law at the University of Cambridge will discuss, 'Can We Regulate AI to Prevent Harm?'. Why It Matters In a time of global complexity and rapid technological advancement, we aim to ensure no one is left behind. By fostering cross-sector collaboration and offering practical tools, Cambridge Forum helps turn big ideas into real-world solutions to address the world's most pressing issues. About Cambridge Forum Cambridge Forum is a training and knowledge-sharing event that provides participants with a unique opportunity to learn. Through practical training and real-world applications, we will discuss how to harness advanced technology in AI and Insurtech to address the world's most pressing challenges and serve underserved communities.


Business Wire
2 hours ago
- Business Wire
Anocca Raises SEK 440 Million to Advance Clinical Trial Targeting Pancreatic Cancer
SÖDERTÄLJE, Sweden--(BUSINESS WIRE)--Anocca AB ('Anocca' or the 'Company'), a leading clinical-stage T-cell immunotherapy company, has successfully raised SEK ~440 million (USD ~46 million) in financing. The additional capital will be used to drive the continued progress of VIDAR-1, Anocca's gene-edited TCR-T cell therapies targeting mutant KRAS in pancreatic cancer, through early-stage clinical development, as well as progress Anocca's preclinical pipeline. The financing was led by Mellby Gård with strong support from AMF, Ramsbury and existing shareholders, alongside new investors. Recruitment is now open for Phase I of the multi-centre trial of VIDAR-1, which is being conducted at leading university hospitals across Sweden, Denmark, Germany and The Netherlands. Reagan Jarvis, co-founder and Chief Executive Officer of Anocca, said: 'We thank our investors for their strong and continued support as we advance our first TCR-T cell therapy products into the clinic. The team has built a unique discovery platform and in-house manufacturing capability, and we are now excited to see the first products reaching patients with high unmet need.' Johan Andersson, Chairman of Mellby Gård, commented: 'We have been invested in Anocca throughout its preclinical development and are pleased to see the Company transition into a clinical stage biotech. We look forward to seeing Anocca help patients that have limited treatment options today with their innovative approach to T-cell therapies.' SEB Corporate Finance acted as financial advisor to Anocca on the finalisation of the transaction, and Mannheimer Swartling and HWF Advokater have acted as legal advisors. ENDS About Anocca Anocca is a fully integrated clinical-stage biopharmaceutical company that develops libraries of T-cell receptor-engineered T cell (TCR-T) therapies to redefine the treatment of solid tumours and other difficult to treat diseases, including infectious and autoimmune diseases. The company has built a unique discovery engine that uses programmable human cells to recreate and manipulate T cell immunity. These proprietary technologies enable scaling of TCR-T cell therapy development, allowing the systematic generation of libraries of products that represent personalised treatments for the broad patient populations. Anocca currently has the broadest pipeline of TCR-T oncology cell therapy treatments. Anocca operates an advanced research and development infrastructure, underpinned by a custom software ecosystem, AnoccaOS, and an in-house cGMP manufacturing and process development facility. Anocca's TCR-T cell therapies are novel discoveries from its platform and manufactured using non-viral gene editing technology at Anocca's facilities in Södertälje, Sweden. 130+ staff from 40+ nations work at Anocca. About the VIDAR-1 clinical programme VIDAR-1 is designed as a multi-product umbrella trial targeting oncogenic driver mutations in KRAS within pancreatic ductal adenocarcinoma (PDAC). It will investigate up to 20 patients per product in a set of phase I/II studies. Phase I is currently conducted at eight sites in four countries with additional countries and sites in phase II. Patients will be eligible to enrol if they have an HLA, and KRAS mutation, matching an available product. More information about the clinical trial can be found at the EU's clinical trials website. About KRAS and PDAC Mutant KRAS is implicated in pancreatic, lung and colorectal cancers. G12V and G12D mutations in KRAS affect around 90% of pancreatic cancer patients. The five-year survival rate of patients with PDAC is less than 10% (1). Despite recent advances there are no definitive treatments for advanced patients at present (2). References 1. Rawla et al (2019). Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 10(1):10–27. doi: 10.14740/wjon1166 2. Hu & O'Reilly (2023). Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol 21, 7–24. doi: 10.1038/s41575-023-00840-w
Yahoo
3 hours ago
- Yahoo
EZVIZ Reshapes Front Door Security with the Y3000FVP Plus, the Flagship Smart Lock to Integrate Facial and Palm Vein Recognition for Ultimate Protection and Convenience
DUBAI, United Arab Emirates, August 18, 2025--(BUSINESS WIRE)--EZVIZ, a global leader in smart home security, proudly announces the launch of its latest flagship innovation, the Y3000FVP Plus, a premium smart lock that combines facial recognition and palm vein recognition for unbeatable security and convenience. With next-generation AI capabilities, multiple unlocking methods, and an enhanced safety design, the Y3000FVP Plus promises to provide homeowners with an unparalleled level of protection, ease of access, and peace of mind. "We're giving homeowners a smarter and more reliable way to protect their home," said Grant Chen, Vice President of EZVIZ. "With the Y3000FVP Plus, EZVIZ leverages the most cutting-edge technology to protect what matters most." Marking its hot debut in the Middle East, EZVIZ has captured the locally upscaling demand for elegant, intelligent home solutions, while witnessing the lack of a hassle-free user experience. Combining product quality with exceptional customer support, EZVIZ has developed its network of professional installers and related services, so the overall user journey can go as smoothly as possible from purchase, installation, and after-sales care. At the heart of the Y3000FVP Plus are its two industry-leading unlocking methods. This smart lock uses localized 3D data processing to guarantee only live, real-time faces are detected, even adapting to various lighting conditions. It reliably identifies individuals between 1.2m and 2m, unaffected by hairstyle, makeup, or glasses. For added convenience, especially in situations where users might be wearing a mask or carrying items, palm vein recognition provides a secure, forgery-resistant alternative. Both methods are powered by a 12nm AI chip and dual-core CPU, ensuring swift, accurate recognition. Furthermore, there are multiple user-friendly access options, from fingerprint scanning for quick entry, to passcodes for guest access, and even app-based remote unlocking for those constantly on the move. Beyond convenience, the Y3000FVP Plus prioritizes front door security. Equipped with a 1080p camera featuring ultra-wide viewing and night vision, the lock ensures clear monitoring at any time of the day or night. Users receive real-time alerts when movement is detected and can review recorded events. For enhanced protection, the lock is fortified with anti-theft features, such as an automatic siren to deter tampering, a C-grade cylinder to block unauthorized access, and long passcodes to safeguard against guessing attempts. View source version on Contacts Charlene Lilixiaolan15@ Sign in to access your portfolio